Mohammed Majam to South Africa
This is a "connection" page, showing publications Mohammed Majam has written about South Africa.
Connection Strength
0,594
-
Results of the Sukuma Ndoda ("Stand up, Man") HIV Self-Screening and Assisted Linkage to Care Project in Johannesburg: A Quasi-Experimental Pre-Post Evaluation. J Acquir Immune Defic Syndr. 2024 08 01; 96(4):367-375.
Score: 0,096
-
Secondary distribution of HIV self-test kits by HIV index and antenatal care clients: implementation and costing results from the STAR Initiative in South Africa. BMC Infect Dis. 2023 Jun 01; 22(Suppl 1):971.
Score: 0,089
-
Implementation of different HIV self-testing models with implications for HIV testing services during the COVID-19 pandemic: study protocol for secondary data analysis of the STAR Initiative in South Africa. BMJ Open. 2021 05 18; 11(5):e048585.
Score: 0,077
-
International citizen project to assess early stage adherence to public health measures for COVID-19 in South Africa. PLoS One. 2021; 16(3):e0248055.
Score: 0,076
-
Progress on the scaling up of HIV testing in South Africa through varied distribution models using the oral HIV self-test kit. Oral Dis. 2020 Sep; 26 Suppl 1:137-140.
Score: 0,074
-
Usability assessment of seven HIV self-test devices conducted with lay-users in Johannesburg, South Africa. PLoS One. 2020; 15(1):e0227198.
Score: 0,070
-
Integration of point-of-care screening for type 2 diabetes mellitus and hypertension with COVID-19 rapid antigen screening in Johannesburg, South Africa. PLoS One. 2023; 18(7):e0287794.
Score: 0,022
-
The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa. BMJ Glob Health. 2021 07; 6(Suppl 4).
Score: 0,019
-
Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe. BMJ Glob Health. 2021 07; 6(Suppl 4).
Score: 0,019
-
The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis. BMJ Glob Health. 2021 07; 6(Suppl 4).
Score: 0,019
-
Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial. J Acquir Immune Defic Syndr. 2019 02 01; 80(2):224-233.
Score: 0,016
-
Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial. BMC Public Health. 2017 Jul 04; 17(Suppl 3):445.
Score: 0,015